Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Uterine cancer]

J Kodama1, T Kudo

  • 1Department of Obstetrics & Gynecology, Okayama University Medical School.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|January 26, 2002
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stage IB1 cervical cancer patients with an MRI-measured tumor size < or = 2 cm might be candidates for less-radical surgery.

European journal of gynaecological oncology·2013
Same author

Complications and obstetric outcomes after laser conization during pregnancy.

European journal of gynaecological oncology·2010
Same author

D-dimer level as a risk factor for postoperative venous thromboembolism in Japanese women with gynecologic cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2010
Same author

Hepatocyte growth factor activator inhibitor-2 (HAI-2) is a favorable prognosis marker and inhibits cell growth through the apoptotic pathway in cervical cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2008
Same author

Phase I study of chemoradiation with nedaplatin and ifosfamide in patients with advanced squamous cell carcinoma of the uterine cervix.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2008
Same author

Phase I study of weekly nedaplatin and concurrent pelvic radiotherapy as adjuvant therapy after radical surgery for cervical cancer.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2007